Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Appointed director
CC transcript
Inv. presentation
Acq. announced
Appointed CFO
|
|
Innoviva, Inc. (INVA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2023 |
SC 13D/A
| Innoviva, Inc. reports a 85.3% stake in ARMATA PHARMACEUTICALS, INC. |
| 05/15/2023 |
SC 13D/A
| Sarissa Capital Management LP reports a 10.5% stake in Innoviva, Inc. |
| 01/10/2023 |
SC 13D/A
| Innoviva, Inc. reports a 85.3% stake in ARMATA PHARMACEUTICALS, INC. |
| 07/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/23/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/01/2022 |
SC 13D/A
| Innoviva, Inc. reports a 80.1% stake in ARMATA PHARMACEUTICALS, INC. |
| 03/15/2022 |
SC 13D/A
| Innoviva, Inc. reports a 74.9% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 02/18/2022 |
SC 13D/A
| Innoviva, Inc. reports a 75.2% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 02/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/01/2022 |
SC 13D/A
| Innoviva, Inc. reports a 75.2% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 11/01/2021 |
SC 13D/A
| Innoviva, Inc. reports a 73.8% stake in ARMATA PHARMACEUTICALS, INC. |
| 06/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/25/2021 |
SC 13D/A
| Sarissa Capital Management LP reports a 9.2% stake in Innoviva, Inc. |
| 05/25/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/03/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/05/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/17/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/12/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/27/2021 |
SC 13D/A
| Innoviva, Inc. reports a 68% stake in ARMATA PHARMACEUTICALS, INC. |
| 12/14/2020 |
SC 13D/A
| Sarissa Capital Management LP reports a 6.3% stake in Innoviva, Inc. |
| 09/01/2020 |
SC 13D/A
| Innoviva, Inc. reports a 69% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 08/31/2020 |
SC 13D/A
| Innoviva, Inc. reports a 67.8% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 06/12/2020 |
SC 13D/A
| Innoviva, Inc. reports a 67.8% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 03/31/2020 |
SC 13D/A
| Innoviva, Inc. reports a 63.7% stake in ARMATA PHARMACEUTICALS, INC. |
| 04/10/2018 |
SC 13D/A
| GLAXOSMITHKLINE PLC reports a 31.4% stake in INNOVIVA, INC. |
| 04/13/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 08/25/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 08/01/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 05/16/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 04/02/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|